Tim Schlidt

https://www.palosanto.vc

The Psychedelics Finance Crunch Seen in the SXSW Funhouse Mirror

When I last came to SXSW, Austin’s high rent version of Mardi Gras, in the ancient mid 90s, it was all about the bands. Times...

Where Did 2022 Take the Psychedelic Medicine Field?

Josh Hardman, the founder of Psychedelic Alpha, reviews the published findings of COMPASS Pathways’ Phase 2b clinical trial and its upcoming Phase 3 program. Psychedelic...

Gilgamesh Tweaks Known Psychedelics To Improve Therapies

Many startup companies developing psychedelic therapies work with classic mind-altering substances such as psilocybin, mescaline and LSD. Jonathan Sporn, the founder and chief executive of...

Tim Schlidt is Funding a New Paradigm in Wellbeing – Podcast Episode #22

On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo. Palo Santo is a leading therapeutics investment fund dedicated to...

Tim Schlidt is Funding a New Paradigm in Wellbeing

On this episode of the Psychedelic Invest Podcast, we welcome Tim Schlidt of Palo Santo. Palo Santo is a leading therapeutics investment fund dedicated to...

Palo Santo

Managing Partner

Last updated: Oct 18, 2022

Request Deletion